High materiality7/10
Vertex Pharmaceuticals price target raised to $615 from $585 at UBS
Why it may matterVerify against the original reporting
Bullish target upgrade
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises VRTX target to $615; current price $528.04; upside potential.
- VRTX tgt raised to 615; price 528.04.
Key facts
- 01
Target: $615
- 02
Posted price: $528.04
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.